0001104659-21-096338.txt : 20210826 0001104659-21-096338.hdr.sgml : 20210826 20210727165427 ACCESSION NUMBER: 0001104659-21-096338 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210727 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAXCYTE, INC. CENTRAL INDEX KEY: 0001287098 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 522210438 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 22 FIRSTFIELD ROAD STREET 2: SUITE 250 CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 301-517-5556 MAIL ADDRESS: STREET 1: 22 FIRSTFIELD ROAD STREET 2: SUITE 250 CITY: GAITHERSBURG STATE: MD ZIP: 20878 FORMER COMPANY: FORMER CONFORMED NAME: MAXCYTE INC DATE OF NAME CHANGE: 20040415 CORRESP 1 filename1.htm

July 27, 2021

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re:	MaxCyte, Inc.

Registration Statement on Form S-1 (File No. 333-257810)

Attn:

Ms. Julia Griffith

Mr. Justin Dobbie

Ms. Amy Geddes

Ms. Linda Cvrkel

Ladies and Gentlemen:

Pursuant to Rule 460 under the Securities Act of 1933, as amended, (the “Act”), we wish to advise you that between July 26, 2021 and the date hereof, approximately 742 copies of the Preliminary Prospectus, dated July 26, 2021, were distributed to prospective underwriters, institutional investors, prospective dealers, individuals and others.

We have been informed by the participating underwriters that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

In accordance with Rule 461 under the Act, we hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:30 p.m., Eastern Time, on July 29, 2021, or as soon thereafter as practicable, or at such other time as the registrant or its counsel may request by telephone call to the Staff of the Division of Corporation Finance of the Securities and Exchange Commission.

[Signature page follows.]

	Very truly yours,

	Cowen and Company, LLC
	Stifel, Nicolaus & Company, Incorporated
	William Blair & Company, L.L.C.
		Acting on their own behalf
		and as Representatives of several
		Underwriters listed on Schedule A to the Underwriting Agreement.

	By:	Cowen and Company, LLC

	By:	/s/ Jay Coleman
		Name: Jay Coleman
		Title: Managing Director

	By:	Stifel, Nicolaus & Company, Incorporated

	By:	/s/ Nathan Thompson
		Name: Nathan Thompson
		Title: Managing Director

	By:	William Blair & Company, L.L.C.

	By:	/s/ Steve Maletzky
		Name: Steve Maletzky
		Title: Managing Director